Literature DB >> 10962264

The case against outpatient parenteral inotropic therapy for advanced heart failure

.   

Abstract

Entities:  

Year:  2000        PMID： 10962264

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  7 in total

1.  Chronic inotropic therapy in end-stage heart failure.

Authors:  Paul J Hauptman; Peter Mikolajczak; Anil George; Clinton J Mohr; Robert Hoover; Jason Swindle; Mark A Schnitzler
Journal:  Am Heart J       Date:  2006-12       Impact factor: 4.749

Review 2.  Symptom management challenges in heart failure: pharmacotherapy considerations.

Authors:  Diana Stewart; Mary Lynn McPherson
Journal:  Heart Fail Rev       Date:  2017-09       Impact factor: 4.214

3.  Effect of levosimendan in patients with acute decompensated heart failure : A meta-analysis.

Authors:  S Zhou; L Zhang; J Li
Journal:  Herz       Date:  2018-04-10       Impact factor: 1.443

4.  Effects of levosimendan/furosemide infusion on plasma brain natriuretic peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients.

Authors:  Mauro Feola; Enrico Lombardo; Camillo Taglieri; Paola Vallauri; Salvatore Piccolo; Roberto Valle
Journal:  Med Sci Monit       Date:  2011-02-25

5.  Repetitive infusion of levosimendan in patients with chronic heart failure: a meta-analysis.

Authors:  Gui-Yan Yi; Jun-Xia Li; Jian Zhang; Li-Li Niu; Cai-Yun Zhang
Journal:  Med Sci Monit       Date:  2015-03-26

6.  Levosimendan improves exercise performance in patients with advanced chronic heart failure.

Authors:  Saima Mushtaq; Daniele Andreini; Stefania Farina; Elisabetta Salvioni; Gianluca Pontone; Susanna Sciomer; Valentina Volpato; Piergiuseppe Agostoni
Journal:  ESC Heart Fail       Date:  2015-08-13

7.  Haemodynamic effects of levosimendan in advanced but stable chronic heart failure.

Authors:  Emil Najjar; Marcus Stålhberg; Camilla Hage; Erica Ottenblad; Aristomenis Manouras; Ida Haugen Löfman; Lars H Lund
Journal:  ESC Heart Fail       Date:  2018-02-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.